BIOPIPER? TZ
Product Description
Biocon Limited
-
IN -
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
Categories
Specifications
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
More Products from Biocon Limited (99)
-
Product Atsure?
Biocon offers a wide range of oncotherapeutic which includes atsure. Composition: gemcitabine hydrochloride usp equivalent to gemcitabine 200mg/1gm/1.4gm. Mechanism of action: emcitabine exhibits cell phase specificity, primarily killing cells undergoing dna synthesis (s-phase) and also blocking the progre... -
Product BASALOG Refil ?
Biocon offers a wide range of metabolic which includes basalog refil ?. Composition: each ml contains insulin glargine (rdna origin) 100 iu. In-use stability: 28 days/4 weeks. Mechanism of action: insulin glargine has low aqueous solubility at neutral ph. At ph 4, as in the glargine injection solution, it ... -
Product BASALOG?
Biocon offers a wide range of metabolic which includes basalog. Composition: insulin glargine (rdna origin) 100 iu. Benzyl alcohol, 1% w/v (as preservative). Mechanism of action: insulin glargine has low aqueous solubility at neutral ph. At ph 4, as in the glargine injection solution, it is completely solu... -
Product BESTOR?
Biocon offers a wide range of metabolic which includes bestor. Composition: rosuvastatin 5mg, 10mg & 20mg. Mechanism of action: rosuvastatin is a member of the drug class of statins used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Rosuvastatin belongs to the cat... -
Product BESTOR? FN
Biocon offers a wide range of metabolic which includes bestor fn. Composition: rosuvastatin 10mg + nanonized fenofibrate 145 mg. Mechanism of action: rosuvastatin: this is a member of the drug class of statins used to treat high cholesterol and related conditions, and to prevent cardiovascular disease, fen... -
Product BIOMAb EGFR?
Biocon offers a wide range of oncotherapeutic which includes biomab egfr?. Composition: recombinant humanized igg1 monoclonal antibody. Mechanism of action: it is a monoclonal antibody that specifically binds to the extracellular domain of the epidermal growth factor receptor (egfr) and prevents signal tra... -
Product BIOSEV?
Biocon offers a wide range of nephrology which includes biosev. Composition: each film-coated tablet contains: sevelamer hydrochloride ? 400mg/ 800mg. Indications: it is indicated for the control of hyperphosphataemia in patients with chronic kidney disease on dialysis -
Product BIOSEV? C - 400
Biocon offers a wide range of nephrology which includes biosev? c - 400. Composition: each film coated tablet contains: sevelamer carbonate 400 mg, excipients q.s. Colour: tartrazine yellow lake, brilliant blue lake and titanium dioxide ip. Mechanism of action: sevelamer is a polymeric compound which acts ... -
Product BIOSEV? C - 800
Biocon offers a wide range of nephrology which includes biosev? c - 800. Composition: each film coated tablet contains: sevelamer carbonate 800 mg, excipients q.s. Colour: ponceau 4r and titanium dioxide ip. Mechanism of action: sevelamer is a polymeric compound which acts by binding to phosphate molecules... -
Product BIVACARD?
Biocon offers a wide range of metabolic which includes bivacard. Composition: bivalirudin for injection 250 mg (lyophilized), each vial contains: bivalirudin 250 mg. Excipients q.s. Mechanism of action: bivalirudin directly inhibits thrombin by specifically binding both to the catalytic site and to the ani... -
Product BLISTO? 1
Biocon offers a wide range of metabolic which includes blisto 1. Composition: glimepiride 1mg, 2mg & 4mg tablets. Mechanism of action: a third generation sulphonylurea, which reduces blood glucose by inducing islet cells of the pancreas to secrete insulin. Glimepiride also has other beneficial effects on m... -
Product BLISTO? 1MF
Biocon offers a wide range of metabolic which includes blisto 1mf. Composition: blisto 1mf - glimepiride 1mg + metforminsr 500mg tablets. Mechanism of action: glimepiride acts by stimulating the release of insulin from functioning pancreatic beta cells. In addition, extra-pancreatic effects may also play a...
Biocon Limited resources (1)
-
News Viatris and Biocon score historic first for interchangeable biosimilar product
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance